Wednesday, September 7, 2016

BRIEF-Takeda initiates Phase 3 clinical trial of dengue vaccine candidate (TAK-003)

* Initiates global Phase 3 clinical trial (TIDES) of dengue

vaccine candidate (TAK-003)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)